Acute coronary syndromes

an ACE inhibitor. [2013] Antiplatelet therapy 1.4.13 Offer aspirin to all people after an MI and continue it indefinitely, unless they are aspirin intolerant or have an indication for anticoagulation (see the section on antiplatelet therapy for people with an ongoing separate indication for anticoagulation). [2007, amended 2013] 1.4.14 Offer aspirin to people who have had an MI more than 12 months ago and continue it indefinitely. [2013] 1.4.15 Continue dual antiplatelet therapy for up to 12 months after an MI unless contraindicated (see recommendations 1.1.11, 1.1.24, 1.1.25, 1.2.17, 1.2.21 and 1.2.22 for more information about dual antiplatelet therapy). [2020] 1.4.16 Ticagrelor with aspirin for up to 3 years is recommended as an option in NICE technology appraisal guidance for preventing atherothrombotic events in people who had an MI more than 12 months ago and are at high risk of a further event. For full details, see the guidance on ticagrelor (TA420, 2016). 1.4.17 For people with aspirin hypersensitivity who have had an MI, clopidogrel monotherapy should be considered as an alternative treatment. [2007] 1.4.18 People with a history of dyspepsia should be considered for treatment in line with the NICE guideline on gastro-oesophageal reflux disease and dyspepsia in adults.
